Remibrutinib and its Impurities
Remibrutinib is an oral Bruton's tyrosine kinase (BTK) inhibitor developed for the treatment of chronic spontaneous urticaria and other immune-mediated inflammatory conditions. Reference standards of Remibrutinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
N-(3-(6-Amino-5-(2-(methyl(nitroso)amino)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide
N-(3-(6-Amino-5-(2-(methyl(nitroso)amino)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide
Catalogue No.:PA 18 1821000
CAS :
3103121-14-5
Molecular Formula : C24H24F2N6O3
Molecular Weight : 482.49
